Walpar Nutri Science Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 26-10-2024
- Paid Up Capital ₹ 7.50 M
as on 26-10-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.95 Cr
as on 26-10-2024
- Satisfied Charges ₹ 1.95 Cr
as on 26-10-2024
- Revenue 49.91%
(FY 2023)
- Profit 219.81%
(FY 2023)
- Ebitda 582.26%
(FY 2023)
- Net Worth -16.05%
(FY 2023)
- Total Assets 5.43%
(FY 2023)
About Walpar Nutri Science
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹1.95 Cr. The company has closed loans amounting to ₹1.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kalpesh Ladhawala, Amit Patel, and Ripal Patel serve as directors at the Company.
- CIN/LLPIN
U36999GJ2020PTC112235
- Company No.
112235
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Walpar Nutri Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalpesh Ladhawala  | Director | 23-Jan-2020 | Current |
| Amit Patel | Director | 23-Jan-2020 | Current |
| Ripal Patel | Director | 14-Dec-2021 | Current |
Financial Performance of Walpar Nutri Science.
Walpar Nutri Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.91% increase. The company also saw a substantial improvement in profitability, with a 219.81% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Walpar Nutri Science?
In 2023, Walpar Nutri Science had a promoter holding of 24.67% and a public holding of 75.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Steer Peau Dermo Cosmetique Private LimitedActive 5 years 6 months
Kalpesh Ladhawala is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Oct 2022 | ₹1.95 Cr | Open |
The South Indian Bank Limited Creation Date: 22 Oct 2020 | ₹1.95 Cr | Satisfied |
How Many Employees Work at Walpar Nutri Science?
Unlock and access historical data on people associated with Walpar Nutri Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Walpar Nutri Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Walpar Nutri Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
